Eiji Tanaka, a Ph.D. and Doctor of Veterinary Medicine, has served as President of Mitsubishi Tanabe Pharma Holdings America Inc. since November 2014. Dr. Tanaka, an experienced toxicologist, joined Mitsubishi Chemical Industries Ltd. in 1981. He previously graduated from Hokkaido University Faculty of Veterinary Medicine and then obtained a Ph.D. in Veterinary Medicine from the Nippon Veterinary and Life Science University in 1992. After his postgraduate program in Pharmacology at the University of Rochester in New York, Dr. Tanaka held managerial positions including Manager of Safety Research Laboratories and Senior Manager of the Licensing Department. From 2004 to 2006, Dr. Tanaka was the Senior Manager of the Corporate Strategic Planning Department. After serving as the General Manager of Business Development and Licensing Department, he became the General Manager and then Associate Director of the International Business Department at Mitsubishi Tanabe Pharma Corp., where he managed business in China, Korea, Taiwan, Indonesia, ASEAN countries, U.S. and Europe. Since April 2014, Dr. Tanaka served as the Executive Officer of the International Business Department.